NCT04094181View on ClinicalTrials.gov

A Study of VPRIV in Participants With Gaucher Disease Previously Treated With Other Enzyme Replacement Therapies or Substrate Reduction Therapies

TerminatedOBSERVATIONAL
Enrollment

2

Participants

Timeline

Start Date

September 19, 2019

Primary Completion Date

November 17, 2021

Study Completion Date

November 17, 2021

Conditions
Gaucher Disease
Trial Locations (1)

T6G 2H7

University of Alberta/Medical Genetics Clinic, Edmonton

Sponsors

Lead Sponsor

Shire
All Listed Sponsors
lead

Shire

INDUSTRY